Clinical Trials in Phoenix

Showing 5961-5980 of 16,646 trials

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

NCT02493530

This is a Phase 1, open-label, study of TGR-1202, a PI3K delta inhibitor, administered together with ruxolitinib in patients with myeloproliferative neoplasms (specifically: polycythemia vera, primary myelofibrosis, PPV-MF or PET-MF) and MDS/MPN.

MyelofibrosisPolycythemia Vera

Vanderbilt-Ingram Cancer Center60 participantsStarted Jul 2015

Phoenix, Arizona, United States • Aurora, Colorado, United States • Nashville, Tennessee, United States +2 more locations

TERMINATED< 1 mile

Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

NCT04149197

The primary objective is to characterize trajectories of change on the primary outcome measures in this study population through longitudinal collection of measures of cognition, function, behavior, and health status.

Alzheimer's Disease in Down Syndrome

LuMind IDSC Foundation252 participantsStarted Jun 2019

Phoenix, Arizona, United States • Irvine, California, United States • La Jolla, California, United States +11 more locations

TGR-1202 + Ruxolitinib PMF PPV-MF PET-MF MDS/MPN Polycythemia Vera Resistant to Hydroxyurea

Down Syndrome Clinical Trials - Study of Alzheimer's Disease in Down Syndrome

Find Trials by Condition in Phoenix

TRC-PAD Program: In-Clinic Trial-Ready Cohort

Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus

Pegloticase and Methotrexate Co-administered in Participants With Uncontrolled Gout Who Previously Failed Pegloticase Monotherapy

Study of Pegloticase (KRYSTEXXA®) Plus Methotrexate in Patients With Uncontrolled Gout

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

A Study Evaluating TEPEZZA® Treatment in Patients With Chronic (Inactive) Thyroid Eye Disease

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Validation of Patient Reported Outcome Measures in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium Complex

Psychotherapy for PTSD Among Veterans Also Receiving Drug or Alcohol Treatment

Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Combination With Chemotherapy in Participants With HER2-Positive Early Breast Cancer

A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders

Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study

A Study With TEPEZZA in Patients With Diffuse Cutaneous Systemic Sclerosis (dcSSc)

Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy

Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis